From: A novel reliability-based regression model to analyze and forecast the severity of COVID-19 patients
Clinical factor | ID | Symbol | Clinical factor | ID | Symbol |
---|---|---|---|---|---|
Albumin/globulin | A/G | X1 | Mean corpuscular hemoglobin | MCH | X26 |
Albumin | ALB | X2 | Mean corpuscular-hemoglobin concentration | MCHC | X27 |
Alkaline phosphatase | ALP | X3 | Mean corpuscular volume | MCV | X28 |
Glutamic-pyruvic transaminase | ALT | X4 | Absolute value of monocytes | Mono# | X29 |
Activated partial thromboplastin time | APTT | X5 | Percentage of monocytes | Mono% | X30 |
Glutamic oxalacetic transaminase | AST | X6 | mean platelet volume | MPV | X31 |
Absolute value of basophil | Baso# | X7 | Platelet large cell ratio | P-LCR | X32 |
Percentage of basophils | Baso% | X8 | PCT plateletocrit | PCT | X33 |
Blood urea nitrogen | BUN | X9 | Platelet distribution width | PDW | X34 |
Creatine Kinase Isoenzyme | CK-MB | X10 | Blood platelet count | PLT | X35 |
Creatinine | CREA | X11 | Prothrombin time | PT | X36 |
C-reactive protein | CRP | X12 | International normalized ratio | PT-INR | X37 |
Cystatin C | CysC | X13 | Red blood cell count | RBC | X38 |
Direct bilirubin | D-BIL | X14 | CV value of RBC distribution width | RDW-CV | X39 |
Absolute value of eosinophils | Eos# | X15 | SD value of erythrocyte distribution width | RDW-SD | X40 |
Percentage of eosinophils | Eos% | X16 | Sialic acid | SA | X41 |
Fibrinogen | FIB | X17 | Total bile acid | TBA | X42 |
Gamma-glutamyl transpeptidase | GGT | X18 | Total bilirubin | TBIL | X43 |
Globulin | GLO | X19 | Thrombin time | TT | X44 |
Glucose (fasting) | GLU | X20 | Uric acid | UA | X45 |
Hemoglobin | Hb | X21 | \({\hat{I}}^2\)2-microglobulin | ÃŽ\(^2\)2-MG | X46 |
Hematocrit value | Hct | X22 | Neutrophil absolute value | Neut# | X47 |
Lactic dehydrogenase | LDH | X23 | Neutrophil percentage | Neut% | X48 |
Lymphocyte absolute value | Lymph# | X24 | D-dimer | SF8200_D-Dimer | X49 |
Percentage of lymphocytes | Lymph% | X25 | Cholinesterase | CHE | X50 |